Is Simulations Plus Inc (SLP) overvalued? · rev $79.2M
Simulations Plus Inc (SLP) is a health information services company listed on NASDAQ.
This page asks whether Simulations Plus Inc (SLP) looks expensive on cached numbers — not a short thesis.
Latest reported SLP revenue for 2025-08-31 was $79.2M. Net income was -$64.7M. Revenue was up 13.1% from 2024-08-31 to 2025-08-31. SLP currently screens at market cap $368.8M.
SLP currently screens at market cap $368.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SLP 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SLP stock page for the full model, not this heading.
Not investment advice.